XPHOZAH is the first and only phosphate absorption inhibitor (PAI) approved by the U.S. Food and Drug Administration to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add ...
Patients with hyperphosphatemia taking an investigational phosphate-binding agent achieved clinical targets with lower pill burden, according to pivotal trial data presented at ASN Kidney Week. The ...
The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...
In the early days of power boiler development, makeup water treatment methods were not firmly established. Operators learned that the transport and accumulation of dissolved ions in boiler water, and ...
Saskatchewan-based mining giant is second-largest producer in North America, its division is valued at US$2.4-billion ...
18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast Cancer Eighty-one patients received treatment. According to International Workshop on Chronic ...
Company’s phosphate division performed poorly in 2024 as Hurricane Helene temporarily shuttered a facility in Florida ...
An innovative gel that forms a layer over teeth and then recruits calcium and phosphate ions from saliva to build new enamel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback